Furthermore, no statistical difference in the prevalence of EGFR mutations was found between the CPFE-LC and isolated IPF-LC groups (6/36, 16.7% vs. 2/13, 15.4%, p = 0.915). The gene discussed is EGFR; the disease is laryngotracheoesophageal cleft.